Benefits of participation in interventation of metabolic syndrome

A COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF HERBAL COMPOUND WITH AND WITHOUT VIRECHAN KARMA IN CASES OF DHATWAGNIMANDYA (W.S.R.TO METABOLIC SYNDROME) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/087732

Enrollment

Registered

2025-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E748- Other specified disorders of carbohydrate metabolism

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria 1. Age- 21- 60 years 2. Fasting glucose 100 mg/dl- 140mg/dl 3. Blood Pressure 130/90 mm Hg-150/110mmHg 4. HDL 40mg/ dl -50mg/dl 5. Waist circumferance 90cm-110cm in men 80cm-100cm in women 6. BMI 25-40 7. Triglyceride 150mg /dl-200mg/dl 8. Patient having all essential criteria and minimum 50%nonessential criteria must be present for selection of cases 9. In the patients minimum 50% objective parameter must be present for selection of cases

Exclusion criteria

Exclusion criteria: Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Objective Parameter 1. Abdominal Obesity 2. BMI above 25 3. High Triglycerides 4. Low HDL cholesterol 5. High Blood pressure or using to lower blood pressure. 6. High fasting blood glucose 7. Increased blood clotting tendency 8. Insulin resistance. 9. High VLDL and VLDL level In the patients minimum 50% objective parameter must be present for selection of cases.Timepoint: before trial,0day,1th month,2 month, 3 month after trial.	—

Measure

Time frame

Objective Parameter 1. Abdominal Obesity 2. BMI above 25 3. High Triglycerides 4. Low HDL cholesterol 5. High Blood pressure or using to lower blood pressure. 6. High fasting blood glucose 7. Increased blood clotting tendency 8. Insulin resistance. 9. High VLDL and VLDL level In the patients minimum 50% objective parameter must be present for selection of cases.Timepoint: before trial,0day,1th month,2 month, 3 month after trial.

—

Secondary

Measure	Time frame
Subjective parameter essential criteria 1.Snigdhaangata(smoothness) 2.Udaraoarshvavriddhi (abdominal obesity) 3.Daurgandhya(foul smell from body) noneseeential criteria 1.Hridyautkleda(heaviness in chest) 2.Prasake(salivation) 3.Kasa(cough) 4.Shwas(breathlessness) patient having all essential criteria and 50% nonessential criteria must be present for selection of cases.Timepoint: before trial,0day,1th month,2 month, 3 month after trial.	—

Measure

Time frame

Subjective parameter essential criteria 1.Snigdhaangata(smoothness) 2.Udaraoarshvavriddhi (abdominal obesity) 3.Daurgandhya(foul smell from body) noneseeential criteria 1.Hridyautkleda(heaviness in chest) 2.Prasake(salivation) 3.Kasa(cough) 4.Shwas(breathlessness) patient having all essential criteria and 50% nonessential criteria must be present for selection of cases.Timepoint: before trial,0day,1th month,2 month, 3 month after trial.

—

Countries

India

Contacts

Public ContactShahnuma Ansari

State Ayurvedic College and Hospital Lucknow

anant10patel@gmail.com9452274856

Outcome results